CURRENT PIPELINE

Swipe from Mobile Devices
STAGE OF DEVELOPMENT
ProgramApproachIndicationDiscoveryLead OptimizationIND Enabling
PLA-GBM™
(Internal)
Platelet-mediated
delivery of
siRNA/miRNA
Glioblastoma2023
PLA-ONCO™
(Out-Licensing)*
or
(For Partnering)*
Platelet-mediated
delivery of siRNA
Solid Tumors2024

(*) Plasfer is actively looking for partners to move this program forward